The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-course targeted therapy with bevacizumab to predict better survival in patients with advanced colorectal cancer.
Yanhong Deng
No relevant relationships to disclose
Yuting Tang
No relevant relationships to disclose
Jian Xiao
No relevant relationships to disclose
Jiayu Ling
No relevant relationships to disclose
Yue Cai
No relevant relationships to disclose
Huabin Hu
No relevant relationships to disclose
Yan Zhang
No relevant relationships to disclose
Yiheng Lin
No relevant relationships to disclose
Dianke Chen
No relevant relationships to disclose